B-hCCL2 MC38

• 321866

B-hCAXII MC38
B-hCCR4 MC38

B-hCCL2 MC38

Product nameB-hCCL2 MC38
Catalog number321866
Strain backgroundC57BL/6
AliasesHC11, MCAF, MCP1, MCP-1, SCYA2,GDCF-2, SMC-CF, HSMCR30
TissueColon
DiseaseColon carcinoma
SpeciesMouse
ApplicationB-hCCL2 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

on this page

  • Description
  • Targeting strategy
  • Phenotypic analysis
  • Tumorigenicity
Description

The mouse Ccl2 gene was replaced by human CCL2 coding sequence in B-hCCL2 MC38 cells. Human CCL2 can be secreted by B-hCCL2 MC38 cells.

Targeting strategy

Gene targeting strategy for B-hCCL2 MC38 cells. The exogenous promoter and human CCL2 coding sequence was inserted to replace part of murine exons 2~3. The insertion disrupts the endogenous murine Ccl2 gene, resulting in a non-functional transcript.

Protein expression analysis

CCL2 expression analysis in B-hCCL2 MC38 cells by ELISA. Human CCL2 was detected in the supernatant of B-hCCL2 MC38 cells but not wild-type MC38 cells. Mouse Ccl2 was not detected in the supernatant of wild-type MC38 cells. The 2-D07 clone of B-hCCL2 MC38 cells was used for in vivo experiments.

Tumor growth curve & Body weight changes
Subcutaneous homograft tumor growth of B-hCCL2 MC38 cells. B-hCCL2 MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6N mice (female, 7-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hCCL2 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.